Study of salivary gland cytopathological lesions and categorized according to Milan reporting system at tertiary care centre Rajkot

Author:

Patel Disha Bipinbhai1,Gandhi Shilpa H1,Dhruva Gauravi H1

Affiliation:

1. PDU Medical College and Hospital, Rajkot, Gujarat, India

Abstract

Classification of salivary gland lesions into 6 diagnostic categories by using Milan Reporting System. Calculate risk of malignancy (ROM) of each category in present study and compare with other similar study. : The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) developed in 2015, aims of MSRSGC to standardize the reporting of salivary gland cytology. It provides a uniform diagnostic terminology that enhances communication between pathologists and clinicians. Moreover, it facilitates the evaluation of data and ensures a precise cytologic and histologic correlation of cases. Ultimately, this system is designed to improve patient care by streamlining the diagnosis process and enabling more accurate treatment decisions. Clinical history and cytology smears of salivary gland lesions, which were diagnosed from October 2022 to September 2023, were retrieved in a P.D.U. medical hospital in Rajkot, Gujarat. The cytology smears were all meticulously reviewed and subsequently classified into one of the six categories as prescribed by MSRSGC. With HPE considered the gold standard, the sensitivity, specificity, positive predictive value, and negative predictive value of FNAC for detecting malignant lesions were meticulously calculated.: A total of 59 salivary gland lesions underwent examination, of which 38 (64.4%) were found in males, and 21 (35.6%) were identified in females. The patients had a median age of 45 years, with ages ranging from 10 to 80 years. It was revealed through statistical analysis that the sensitivity, specificity, positive predictive value, and negative predictive value were determined to be 80%, 100%, 100%, and 88%, respectively. : MSRSGC serves as an effective framework for the categorization of salivary gland tumors, be they benign or malignant. Our findings reflect the positive contribution of the MSRSGC towards accurately identifying the malignant lesions and thus further helping the clinicians regarding the specific management decisions.

Publisher

IP Innovative Publication Pvt Ltd

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3